This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ensign Expands Presence in Nebraska With Two Acquisitions
by Zacks Equity Research
ENSG's acquisitions in Nebraska are expected to strengthen its portfolio in the region, leading to improved skilled services revenues in the future.
Brookdale Bets Big With $610M Acquisitions Amid Debt Refinancing
by Zacks Equity Research
These acquisitions will add 2,789 units to BKD's owned portfolio and enable it to increase its owned units to 66% of its total units.
Can Tenet Healthcare's $910M Divestment in Alabama Cure its Debt Woes?
by Zacks Equity Research
More such divestments can be expected from THC in the coming days, which will likely fuel the company's de-leveraging initiatives.
Acadia Healthcare (ACHC) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
Acadia Healthcare (ACHC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Down -22.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Acadia Healthcare (ACHC)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Acadia Healthcare (ACHC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Smart Investors Are Holding Acadia Healthcare Stock Now: Here's Why
by Zacks Equity Research
ACHC is expected to benefit from improved volumes, patient day growth and expansion initiatives.
Why Is Acadia Healthcare (ACHC) Up 9.1% Since Last Earnings Report?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Acadia Healthcare Expands Behavioral Health Services in Iowa
by Zacks Equity Research
ACHC breaks ground on a new behavioral health hospital in Council Bluffs, addressing regional care shortages through a joint venture with Methodist Health System.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.
5 Hospital Stocks Poised to Benefit From Strong Industry Growth
by Kaibalya Pravo Dey
The Zacks Medical-Hospital industry will gain from increasing admissions and cybersecurity and technological advancements. Companies like HCA, UHS, THC, ACHC and CYH are poised to gain from these trends.
Here's Why Investors Should Hold Acadia (ACHC) Stock for Now
by Zacks Equity Research
Acadia Healthcare (ACHC) remains well-poised for growth on the back of the solid demand for behavioral healthcare services, continuous pursuit of expansion initiatives and a notable financial position.
Encompass Health (EHC) Stock Down 6% Despite Q2 Earnings Beat
by Zacks Equity Research
Encompass Health's (EHC) Q2 results reflect improved net patient revenue per discharge, partly offset by higher costs. It currently estimates 2024 adjusted EPS within $3.97-$4.22, up from the earlier view of $3.86-$4.11.
Acadia Healthcare (ACHC) Shares Up 12% on Q2 Earnings Beat
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q2 results reflect higher revenue per patient day and increased patient days. It currently estimates 2024 adjusted EPS within $3.45-$3.65 compared with the earlier view of $3.40-$3.70.
Acadia Healthcare (ACHC) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 3.41% and 1.54%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Tenet Healthcare (THC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 22.22% and 2.49%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
HCA Healthcare (HCA) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 10.66% and 2.22%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Acadia Healthcare (ACHC) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
Acadia Healthcare (ACHC) Up 0.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health Systems are part of the Zacks Industry Outlook article.
Do Options Traders Know Something About Acadia Healthcare (ACHC) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
5 Hospital Stocks Set to Gain From Robust Industry Trends
by Kaibalya Pravo Dey
The Zacks Medical-Hospital industry is gaining from growing patient volumes, utilization rates and technological advancements. Companies like HCA, THC, UHS, ACHC and CYH are expected to gain from these trends.
Acadia (ACHC), Geisinger JV Begin Construction of New Hospital
by Zacks Equity Research
The new hospital from Acadia (ACHC) and Geisinger JV is scheduled to open in spring 2025.
Acadia Healthcare (ACHC) Shares Down 9% Despite Q1 Earnings Beat
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q1 results aided by improved revenue per patient day, partly offset by escalating costs. It continues to expect 2024 adjusted EPS within $3.40-$3.70.
Acadia Healthcare (ACHC) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 5% and 1.20%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Tenet Healthcare (THC) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 122.07% and 4.42%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?